As mentioned above, the promoter of the survivin gene has many SP1-binding sites, and it has been shown that Tanshinone IIA may exert neuroprotective effects after ischemia through the activation of the SP1/survivin pathway (Tang et al., 2019). The gene discussed is BIRC5; the disease is ischemia.